MORE', SONIA
 Distribuzione geografica
Continente #
NA - Nord America 133
EU - Europa 64
AS - Asia 15
SA - Sud America 4
Totale 216
Nazione #
US - Stati Uniti d'America 133
IT - Italia 33
IE - Irlanda 19
CN - Cina 9
SG - Singapore 6
GB - Regno Unito 4
SE - Svezia 4
BR - Brasile 2
FI - Finlandia 2
FR - Francia 2
PE - Perù 2
Totale 216
Città #
Boardman 24
Chandler 22
Dublin 19
Ashburn 9
Lawrence 6
Princeton 6
Fairfield 5
Redmond 5
Osimo 4
Washington 4
Corridonia 3
Falconara Marittima 3
Turin 3
Altamura 2
Centro 2
Guangzhou 2
Guiyang 2
Helsinki 2
Lima 2
Rome 2
San Benedetto del Tronto 2
San Diego 2
Santa Clara 2
Secaucus 2
São Paulo 2
Xi'an 2
Ann Arbor 1
Houston 1
Islington 1
Kilburn 1
London 1
Los Angeles 1
Miami 1
Seattle 1
Shenzhen 1
Weehawken 1
Yiwu 1
Totale 150
Nome #
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 46
Developments in consolidation and maintenance strategies in post-remission multiple myeloma 26
Real‐world assessment of treatment patterns and outcomes in patients with relapsed‐refractory multiple myeloma in an Italian haematological tertiary care centre 22
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 21
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 21
Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety 20
Novel Experimental Drugs for Treatment of Multiple Myeloma 16
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments 16
Current Main Topics in Multiple Myeloma 15
Monoclonal antibodies: Leading actors in the relapsed/refractory multiple myeloma treatment 15
Novel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment 7
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights 5
Effect of daratumumab on stem cell yields in patients with newly diagnosed multiple myeloma: a report from the Multiple Myeloma Group 5
Editorial: Reviews in hematologic malignancies 2
Plasma cell leukemia: first diagnostic approach in the laboratory|Leucemia plasmacellulare: primo inquadramento diagnostico in laboratorio 2
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma 2
Belantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences 2
Sequential Bispecific Antibodies in Functional and Clinical High Risk Multiple Myeloma, Manifesting with Extramedullary Disease at Relapse: A Case Report 2
Belantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy 2
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review 2
Subcutaneous bortezomib-containing regimens as up-front treatment of newly diagnosed transplant-eligible multiple myeloma patients: a retrospective, non-interventional observational study 1
Totale 250
Categoria #
all - tutte 2.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 0 0 0 0 10 0 6 2 7 7
2022/202372 8 7 8 3 5 3 0 3 16 0 13 6
2023/2024146 22 3 7 5 22 6 3 6 8 8 26 30
Totale 250